Literature DB >> 6403533

A role for cyclooxygenase products in the formation of phosphatidic acid in stimulated human platelets. Differential mechanisms of action of thrombin and collagen.

W Siess, P Cuatrecasas, E G Lapetina.   

Abstract

Human platelets prelabeled with (32P)orthophosphate or [14C]arachidonic acid (AA) were stimulated with collagen or thrombin, and platelet activation (shape change, aggregation, and release of serotonin) was determined in parallel to the formation of 32P- or 14C-labeled phosphatidic acid (PA). The results show a close correlation between the degree of platelet activation and the amount of PA formed. Activation of platelets and formation of PA induced by collagen (2 to 20 micrograms/ml) was blocked by pretreatment of platelets with trifluoperazine, indomethacin, aspirin, or N-methylimidazole. This suggests that the formation of AA by phospholipase A2 and its subsequent metabolism by cyclooxygenase and thromboxane synthetase are required for the collagen-induced formation of PA. Endoperoxide analog U-44069 induces formation of PA in human platelets that have been pretreated with or without aspirin. The action of thrombin does not follow the same pattern of collagen. Low concentrations of thrombin (0.05 units/ml) induce only platelet shape change and a small stimulation of PA, changes which are only minimally inhibited by indomethacin. However, a small increase in the thrombin concentration (to 0.1 unit/ml) induces platelet aggregation, release of serotonin, and a sharp increase in PA accumulation which are effectively inhibited by indomethacin. Even higher thrombin concentrations (0.4 to 0.8 units/ml), however, result in a further stimulation of PA formation, platelet aggregation, and release of serotonin which are insensitive to inhibition by indomethacin. The data show that cyclooxygenase metabolites of AA, produced after platelet activation, may be differentially involved in the formation of PA in platelets stimulated with collagen or thrombin. Formation of PA following collagen or intermediate concentrations of thrombin (0.1 to 0.2 units/ml) is dependent on the cyclooxygenase pathway. However, formation of PA by very low or by high concentrations of thrombin is not mediated by cyclooxygenase metabolites of AA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403533

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

2.  Liberation of [3H]arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen.

Authors:  W K Pollock; T J Rink; R F Irvine
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

3.  Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin.

Authors:  L F Brass; C C Shaller; E J Belmonte
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

4.  BW755C or staurosporine inhibits collagen-stimulated phosphoinositide phosphorylation in platelets.

Authors:  L M Thomas; B J Holub
Journal:  Lipids       Date:  1991-09       Impact factor: 1.880

5.  Effect of alpha 2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  H Takeda; H Kishikawa; M Shinohara; T Miyata; K Suzaki; H Fukushima; K Ichinose; M Shichiri
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

6.  Analgesic, anti-inflammatory and anti-platelet activities of the methanolic extract of Acacia modesta leaves.

Authors:  Ishfaq A Bukhari; Rafeeq A Khan; Anwar H Gilani; Sagheer Ahmed; Sheikh Arshad Saeed
Journal:  Inflammopharmacology       Date:  2010-08       Impact factor: 4.473

7.  Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2.

Authors:  T J Hallam; A Sanchez; T J Rink
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

8.  Aggregation and/or oxygenated products of arachidonic acid are not required for collagen-induced deacylation of phosphatidylcholine in human platelets.

Authors:  L A Piché; V G Mahadevappa
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

9.  The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.

Authors:  M L Taylor; N L Misso; G A Stewart; P J Thompson
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

10.  Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.

Authors:  W K Pollock; R A Armstrong; L J Brydon; R L Jones; D E MacIntyre
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.